Literature DB >> 29040213

Importance of the Complement Alternative Pathway in Serum Chemotactic Activity During Sepsis.

Ganqiong Xu1,2, Yan Feng1,3, Dan Li1, Qichang Zhou2, Wei Chao1,3, Lin Zou1,3.   

Abstract

Serum chemotactic activity is important in regulating neutrophil migration. The ability of neutrophils to migrate to infectious site is crucial for host effective pathogen control, but unregulated neutrophil activation can also cause tissue damage. During bacterial sepsis, the complement alternative pathway (AP) is massively activated in blood and tissues and reportedly contributes to sepsis pathogenesis. Complement factor B (FB) is an essential component of the AP activation. However, the impact of FB/AP activation on blood chemotactic activity during bacterial infection is unclear. In this study, we found that sera of septic mice following cecal ligation and puncture (CLP) had much higher chemotactic activities on neutrophils than those of sham animals. Compared with wild-type (WT) mice, FB mice had significantly attenuated serum chemotactic activity, under both nonseptic and septic conditions. Moreover, sera with the activated AP by zymosan and cobra venom factor (CVF) in vitro induced a significant increase in neutrophil migration compared with sera without the AP activation. Complement activation generates complement cleavage fragment such as Ba, C3a, and C5a. To delineate the contribution of these downstream effectors, we incubated AP-active sera (AP activated by zymosan/CVF) or sera from sham and septic mice with anti-C5a or mAb1379 (anti-Ba) neutralizing antibody. We found that anti-C5a, but not mAb1379, markedly attenuated the neutrophil chemotactic effect of the AP-activated sera and that of septic sera. Taking together, these data suggest that the complement AP activation during bacterial sepsis plays a pivotal role in promoting blood chemotactic activity through a C5a-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29040213      PMCID: PMC6462261          DOI: 10.1097/SHK.0000000000001031

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  25 in total

Review 1.  Neutrophil paralysis in sepsis.

Authors:  José C Alves-Filho; Fernando Spiller; Fernando Q Cunha
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation.

Authors:  P Brandtzaeg; K Høgåsen; P Kierulf; T E Mollnes
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

5.  Nonhematopoietic toll-like receptor 2 contributes to neutrophil and cardiac function impairment during polymicrobial sepsis.

Authors:  Lin Zou; Yan Feng; Ming Zhang; Yan Li; Wei Chao
Journal:  Shock       Date:  2011-10       Impact factor: 3.454

Review 6.  Neutrophil migration in infection and wound repair: going forward in reverse.

Authors:  Sofia de Oliveira; Emily E Rosowski; Anna Huttenlocher
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

7.  Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis.

Authors:  Lin Zou; Yan Feng; Yan Li; Ming Zhang; Chan Chen; Jiayan Cai; Yu Gong; Larry Wang; Joshua M Thurman; Xiaobo Wu; John P Atkinson; Wei Chao
Journal:  J Immunol       Date:  2013-10-23       Impact factor: 5.422

8.  A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.

Authors:  Joshua M Thurman; Damian M Kraus; Guillermina Girardi; Dennis Hourcade; Hee J Kang; Pamela A Royer; Lynne M Mitchell; Patricia C Giclas; Jane Salmon; Gary Gilkeson; V Michael Holers
Journal:  Mol Immunol       Date:  2005-01       Impact factor: 4.407

9.  Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo.

Authors:  Bartomeu Colom; Jennifer V Bodkin; Martina Beyrau; Abigail Woodfin; Christiane Ody; Claire Rourke; Triantafyllos Chavakis; Karim Brohi; Beat A Imhof; Sussan Nourshargh
Journal:  Immunity       Date:  2015-06-02       Impact factor: 31.745

10.  Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice.

Authors:  Iris Leinhase; Michal Rozanski; Denise Harhausen; Joshua M Thurman; Oliver I Schmidt; Amir M Hossini; Mohy E Taha; Daniel Rittirsch; Peter A Ward; V Michael Holers; Wolfgang Ertel; Philip F Stahel
Journal:  J Neuroinflammation       Date:  2007-05-02       Impact factor: 8.322

View more
  5 in total

1.  The Influence of Pain and Analgesia in Rodent Models of Sepsis.

Authors:  Kelsey C Carpenter; John M Hakenjos; Christopher D Fry; Jean A Nemzek
Journal:  Comp Med       Date:  2019-06-18       Impact factor: 0.982

Review 2.  Emerging roles of the complement system in host-pathogen interactions.

Authors:  Sanjaya K Sahu; Devesha H Kulkarni; Ayse N Ozanturk; Lina Ma; Hrishikesh S Kulkarni
Journal:  Trends Microbiol       Date:  2021-09-29       Impact factor: 17.079

3.  Neutrophil extracellular trap formation index predicts occurrences of deep surgical site infection after laparotomy.

Authors:  Zehua Duan; Shilong Sun; Cheng Qu; Kai Wang; Fang Chen; Xinyu Wang; Chengnan Chu; Baochen Liu; Jieshou Li; Weiwei Ding
Journal:  Ann Transl Med       Date:  2021-09

4.  Cobra Venom Factor Boosts Arteriogenesis in Mice.

Authors:  Philipp Götz; Sharon O Azubuike-Osu; Anna Braumandl; Christoph Arnholdt; Matthias Kübler; Lisa Richter; Manuel Lasch; Lisa Bobrowski; Klaus T Preissner; Elisabeth Deindl
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

Review 5.  Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.

Authors:  Danielle Brain; Alex Plant-Hately; Bethany Heaton; Usman Arshad; Christopher David; Christian Hedrich; Andrew Owen; Neill J Liptrott
Journal:  Adv Drug Deliv Rev       Date:  2021-06-25       Impact factor: 17.873

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.